Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05817_nanopub.RATQb5iwxnvwTJ2NoCGNziaAuGxiC5cgyVGUFFiTFVamc#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB05817 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05817 label "VNP 40101M [drugbank:DB05817]" assertion.
- drugbank:DB05817 seeAlso DB05817 assertion.
- drugbank:DB05817 description "VNP40101M is a novel alkylating agent that is being evaluated for the treatment of acute myelogenous leukemia (AML. It is undergoing phase III development for the treatment of acute myeloid leukemia (AML) and earlier clinical trials for a range of other cancers." assertion.
- drugbank:DB05817 identifier "drugbank:DB05817" assertion.
- drugbank:DB05817 title "VNP 40101M" assertion.
- drugbank:DB05817 drugbank_vocabulary:x-pubchemcompound pubchem.compound:3081349 assertion.
- drugbank:DB05817 drugbank_vocabulary:x-chemspider chemspider:2338969 assertion.
- drugbank:DB05817 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05817 drugbank_vocabulary:drugbank-id "DB05817" assertion.
- drugbank:DB05817 bio2rdf_vocabulary:x-identifiers.org DB05817 assertion.
- drugbank:DB05817 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05817" assertion.
- drugbank:DB05817 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05817 bio2rdf_vocabulary:identifier "DB05817" assertion.